Showing results (311-320 of 343) with videos related to
Sort By:
Pageof 35
Science Signaling|July 23, 2020
Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migrationMichael A Casasanta, Christopher C Yoo, Barath Udayasuryan, et al.British Journal of Cancer|March 6, 2003
Carcinosarcoma of the ovaryM A Harris, L M Delap, P S Sengupta, et al.ACS Chemical Biology|January 27, 2015
Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor designDaniel J Slade, Pengfei Fang, Christina J Dreyton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Regulation of fibroblast growth factor-2 activity by human ovarian cancer tumor endotheliumMelissa K Whitworth, Alison C Backen, Andrew R Clamp, et al.British Journal of Cancer|November 27, 2008
Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatmentM J Slade, R Payne, S Riethdorf, et al.Inorganic Chemistry|December 10, 2021
A Low-Temperature Structural Transition in Canfieldite, Ag8SnS6, Single CrystalsTyler J Slade, Volodymyr Gvozdetskyi, John M Wilde, et al.Journal of the American Chemical Society|July 7, 2020
Contrasting SnTe-NaSbTe2 and SnTe-NaBiTe2 Thermoelectric Alloys: High Performance Facilitated by Increased Cation Vacancies and Lattice SofteningTyler J Slade, Koushik Pal, Jann A Grovogui, et al.Gut Microbes|May 6, 2024
Spatial transcriptomic analysis reveals local effects of intratumoral fusobacterial infection on DNA damage and immune signaling in rectal cancerWilliam P Duggan, Batuhan Kisakol, Ina Woods, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 2023
Strong enhancement of magnetic ordering temperature and structural/valence transitions in EuPd3S4 under high pressureShuyuan Huyan, Dominic H Ryan, Tyler J Slade, et al.The Lancet. Oncology|June 1, 2005
Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trialAndreas Polychronis, H Dudley Sinnett, Dimitri Hadjiminas, et al.Pageof 35